204 related articles for article (PubMed ID: 25692672)
1. A non-aggregated and tumour-associated macrophage-targeted photosensitiser for photodynamic therapy: a novel zinc(II) phthalocyanine containing octa-sulphonates.
Li XS; Ke MR; Zhang MF; Tang QQ; Zheng BY; Huang JD
Chem Commun (Camb); 2015 Mar; 51(22):4704-7. PubMed ID: 25692672
[TBL] [Abstract][Full Text] [Related]
2. C-Phycocyanin as a tumour-associated macrophage-targeted photosensitiser and a vehicle of phthalocyanine for enhanced photodynamic therapy.
Wan DH; Zheng BY; Ke MR; Duan JY; Zheng YQ; Yeh CK; Huang JD
Chem Commun (Camb); 2017 Apr; 53(29):4112-4115. PubMed ID: 28349131
[TBL] [Abstract][Full Text] [Related]
3. In vitro photodynamic activities of zinc(II) phthalocyanines substituted with pyridine moieties.
Liu JY; Li J; Yuan X; Wang WM; Xue JP
Photodiagnosis Photodyn Ther; 2016 Mar; 13():341-343. PubMed ID: 26192694
[No Abstract] [Full Text] [Related]
4. A novel strategy for targeting photodynamic therapy. Molecular combo of photodynamic agent zinc(II) phthalocyanine and small molecule target-based anticancer drug erlotinib.
Zhang FL; Huang Q; Zheng K; Li J; Liu JY; Xue JP
Chem Commun (Camb); 2013 Oct; 49(83):9570-2. PubMed ID: 24018863
[TBL] [Abstract][Full Text] [Related]
5. Water-soluble non-aggregating zinc phthalocyanine and in vitro studies for photodynamic therapy.
Makhseed S; Machacek M; Alfadly W; Tuhl A; Vinodh M; Simunek T; Novakova V; Kubat P; Rudolf E; Zimcik P
Chem Commun (Camb); 2013 Dec; 49(95):11149-51. PubMed ID: 24040651
[TBL] [Abstract][Full Text] [Related]
6. A monomeric photosensitizer for targeted cancer therapy.
Liang R; Ma L; Zhang L; Li C; Liu W; Wei M; Yan D; Evans DG; Duan X
Chem Commun (Camb); 2014 Dec; 50(95):14983-6. PubMed ID: 25327438
[TBL] [Abstract][Full Text] [Related]
7. Cancer targeting with biomolecules: a comparative study of photodynamic therapy efficacy using antibody or lectin conjugated phthalocyanine-PEG gold nanoparticles.
Obaid G; Chambrier I; Cook MJ; Russell DA
Photochem Photobiol Sci; 2015 Apr; 14(4):737-47. PubMed ID: 25604735
[TBL] [Abstract][Full Text] [Related]
8. Highly positive-charged zinc(II) phthalocyanine as non-aggregated and efficient antifungal photosensitizer.
Li XS; Guo J; Zhuang JJ; Zheng BY; Ke MR; Huang JD
Bioorg Med Chem Lett; 2015 Jun; 25(11):2386-9. PubMed ID: 25911302
[TBL] [Abstract][Full Text] [Related]
9. Molecular-target-based anticancer photosensitizer: synthesis and in vitro photodynamic activity of erlotinib-zinc(II) phthalocyanine conjugates.
Zhang FL; Huang Q; Liu JY; Huang MD; Xue JP
ChemMedChem; 2015 Feb; 10(2):312-20. PubMed ID: 25336150
[TBL] [Abstract][Full Text] [Related]
10. A Biotinylated and Endoplasmic Reticulum-Targeted Glutathione-Responsive Zinc(II) Phthalocyanine for Targeted Photodynamic Therapy.
Yu L; Wang Q; Yeung KW; Fong WP; Lo PC
Chem Asian J; 2018 Nov; 13(22):3509-3517. PubMed ID: 29956487
[TBL] [Abstract][Full Text] [Related]
11. Photosensitizer enhanced disassembly of amphiphilic micelle for ROS-response targeted tumor therapy in vivo.
Dai L; Yu Y; Luo Z; Li M; Chen W; Shen X; Chen F; Sun Q; Zhang Q; Gu H; Cai K
Biomaterials; 2016 Oct; 104():1-17. PubMed ID: 27423095
[TBL] [Abstract][Full Text] [Related]
12. In vitro evaluation of combined hyperthermia and photodynamic effects using magnetoliposomes loaded with cucurbituril zinc phthalocyanine complex on melanoma.
Bolfarini GC; Siqueira-Moura MP; Demets GJ; Morais PC; Tedesco AC
J Photochem Photobiol B; 2012 Oct; 115():1-4. PubMed ID: 22854225
[TBL] [Abstract][Full Text] [Related]
13. Selective Photokilling of Human Pancreatic Cancer Cells Using Cetuximab-Targeted Mesoporous Silica Nanoparticles for Delivery of Zinc Phthalocyanine.
Er Ö; Colak SG; Ocakoglu K; Ince M; Bresolí-Obach R; Mora M; Sagristá ML; Yurt F; Nonell S
Molecules; 2018 Oct; 23(11):. PubMed ID: 30355983
[TBL] [Abstract][Full Text] [Related]
14. An acid-cleavable phthalocyanine tetramer as an activatable photosensitiser for photodynamic therapy.
Chow SY; Lo PC; Ng DK
Dalton Trans; 2016 Aug; 45(33):13021-4. PubMed ID: 27396392
[TBL] [Abstract][Full Text] [Related]
15. Enhanced photodynamic efficacy of zinc phthalocyanine by conjugating to heptalysine.
Li L; Luo Z; Chen Z; Chen J; Zhou S; Xu P; Hu P; Wang J; Chen N; Huang J; Huang M
Bioconjug Chem; 2012 Nov; 23(11):2168-72. PubMed ID: 23057652
[TBL] [Abstract][Full Text] [Related]
16. Delivery of a hydrophobic phthalocyanine photosensitizer using PEGylated gold nanoparticle conjugates for the in vivo photodynamic therapy of amelanotic melanoma.
Camerin M; Moreno M; Marín MJ; Schofield CL; Chambrier I; Cook MJ; Coppellotti O; Jori G; Russell DA
Photochem Photobiol Sci; 2016 May; 15(5):618-25. PubMed ID: 27064601
[TBL] [Abstract][Full Text] [Related]
17. A tumor-targeted Ganetespib-zinc phthalocyanine conjugate for synergistic chemo-photodynamic therapy.
Huang L; Wei G; Sun X; Jiang Y; Huang Z; Huang Y; Shen Y; Xu X; Liao Y; Zhao C
Eur J Med Chem; 2018 May; 151():294-303. PubMed ID: 29627724
[TBL] [Abstract][Full Text] [Related]
18. A pH-responsive stellate mesoporous silica based nanophotosensitizer for in vivo cancer diagnosis and targeted photodynamic therapy.
Lin AL; Li SZ; Xu CH; Li XS; Zheng BY; Gu JJ; Ke MR; Huang JD
Biomater Sci; 2018 Dec; 7(1):211-219. PubMed ID: 30426113
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of topical photodynamic therapy of mammary carcinoma with an experimental gel containing liposomal hydroxyl-aluminium phthalocyanine.
Sutoris K; Vetvicka D; Horak L; Benes J; Nekvasil M; Jezek P; Zadinova M; Pouckova P
Anticancer Res; 2012 Sep; 32(9):3769-74. PubMed ID: 22993318
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic modification of disulfonated aluminium phthalocyanine fluorescence in a macrophage cell line.
Kunz L; Connelly JP; Woodhams JH; MacRobert AJ
Photochem Photobiol Sci; 2007 Sep; 6(9):940-8. PubMed ID: 17721592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
